v3.26.1
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 42,339 $ 27,720 $ 79,957 $ 89,009
General and administrative 10,352 5,903 18,844 11,386
Total operating expenses 52,691 33,623 98,801 100,395
Operating loss (52,691) (33,623) (98,801) (100,395)
Interest and investment income 2,798 2,224 5,588 4,609
Net loss (49,893) (31,399) (93,213) (95,786)
Unrealized gain (loss) on investments 3 (1) (282) 193
Total other comprehensive gain (loss) 3 (1) (282) 193
Total comprehensive loss $ (49,890) $ (31,400) $ (93,495) $ (95,593)
Share information:        
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (1.05) $ (0.9) $ (2.01) $ (2.78)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (1.05) $ (0.9) $ (2.01) $ (2.78)
Weighted-average shares of common stock outstanding, basic (in shares) 47,606,857 35,006,114 46,351,614 34,455,585
Weighted-average shares of common stock outstanding, diluted (in shares) 47,606,857 35,006,114 46,351,614 34,455,585